Medical Devices/Healthcare Analysts, along with expert Mark Richardson, MD, PhD, participate in an Analyst/Industry conference call (relevant companies NPCE and CLPT) to be held on November 27 at 11 am. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on NPCE:
- NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference
- NeuroPace price target raised to $8 from $6 at Morgan Stanley
- NeuroPace initiated with an Overweight at Cantor Fitzgerald
- NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
- NPCE Earnings Report this Week: Is It a Buy, Ahead of Earnings?